$ENR

Monday’s insider activity: Major buys at Energizer, sells at SharkNinja By Investing.com

Investing.com reported Monday insider trading filings. Energizer (ENR): reporting owners bought 60,000 shares for about $1.23M at ~$20.20-$20.75. Gloo (GLOO): Grace & Mercy Foundation bought 923,076 shares for ~$3.00M. IPERIONX (IPX): CEO and chairman bought shares totaling about $2.38M. Arista (ANET): CEO sold 242,422 shares for ~$45.6M. Dell (DELL): Silver Lake sold about 124,598 shares for ~$58.1M.

Original reporting
Published Jul 14, 2026, 1:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 14, 2026, 1:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ENR
Bullish
medium confidence
Mentioned
$ENR · $GLOO · $IPX · $CAI · $ANET · $DELL
Relevance
4/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$ENRBullishLow
01

Why it matters

For traders, the actionable element is sentiment and near-term supply/demand read from large insider or major-holder transactions. However, the article does not include new earnings, guidance, contracts, trials, or regulatory decisions, so it is unlikely to drive durable repricing by itself.

02

Market read

This is a sentiment and positioning read from insider/major-holder transactions, not a fundamental update.

03

What to watch

The article does not provide the insiders’ cost basis, tax considerations, or whether buys/sells are part of pre-planned programs, which can weaken causal inference about future performance.

Relevance 4/10Novelty 3/10Timing: insider transactions disclosed for Monday, July 13, 2026

Background

The piece is a roundup of notable insider trading disclosures for July 13, 2026, listing several buys and sells with transaction sizes and price ranges.

Company-level read

Ticker impact

$ENRBullishMedium confidence
Context

Energizer insiders and affiliated reporting owners bought 60,000 shares for about $1.23M at roughly $20.20 to $20.75 on July 9-10.

Expected impact

Low probability of sustained upside solely from this flow; expect limited reaction unless paired with earnings or guidance.

Evidence & confidence

The article reports Form 4-style insider purchases and cites valuation metrics, but provides no new company-specific operational or financial update.

$GLOOBullishLow confidence
Context

Grace & Mercy Foundation increased its stake, buying 923,076 Gloo Holdings Class A shares at $3.25 on July 9, with the deal tied to a closed offering.

Expected impact

Potential short-term support, but likely muted unless the offering terms or follow-on demand change.

Evidence & confidence

The text describes a committed purchase underwritten public offering, which may reflect participation rather than a fresh view on fundamentals.

$IPXBullishMedium confidence
Context

IPERIONX CEO Anastasios Arima bought 138,720 shares around A$3.58 on July 10, and Executive Chairman Todd Hannigan bought additional shares on July 10 and July 13.

Expected impact

Short-term bid possible; follow-through depends on whether the selloff has a fundamental driver not addressed here.

Evidence & confidence

The article provides transaction details and notes the stock is down materially over 6 months, but does not disclose new trial, contract, or guidance information.

$CAIBullishHigh confidence
Context

Caris Life Sciences director Jon Halbert (via LAH Investments) bought 68,000 shares at a weighted average $14.56 on May 15, 2026.

Expected impact

Limited incremental impact today; any effect is likely already priced in.

Evidence & confidence

The newest disclosed fact is an insider transaction, but it occurred about two months prior to the article date and includes no new forward-looking catalyst.

$ANETBearishMedium confidence
Context

Arista Networks CEO/Chairperson Jayshree Ullal sold 242,422 shares for about $45.6M at roughly $187 to $189 on July 9 under Rule 10b5-1 plans.

Expected impact

Near-term downside bias possible, though likely temporary if no other negative news emerges.

Evidence & confidence

The article provides transaction size, pricing range, and 10b5-1 context, but does not connect the sale to any new negative fundamental development.

$DELLBearishMedium confidence
Context

Silver Lake and related entities sold Dell shares totaling about $58.1M at weighted average prices around $448 to $460 on July 9 after converting Class B to Class C.

Expected impact

Mild negative sentiment impact possible; magnitude likely limited because it is framed as conversion and planned selling.

Evidence & confidence

The article includes detailed transaction mechanics and timing, but insider sales are not the same as a company guidance change.

$PRMBearishMedium confidence
Context

WindAcre Partnership Master Fund sold Perimeter Solutions ordinary shares totaling about $195.6M between June 26 and June 30 at $33.00 to $36.25.

Expected impact

Potential short-term pressure if the market interprets it as reduced conviction, but follow-through uncertain without new fundamentals.

Evidence & confidence

The article provides the size and price range of the sale, yet it does not disclose why the holder exited or any new company-specific deterioration.

Market effects

No clear sector-wide catalyst; this is primarily single-name insider flow information across consumer, tech, and healthcare-adjacent names.

Primarily US-listed equities; IPX transactions reference Australian Stock Exchange trading for the ordinary shares.

Limited, as the article does not describe cross-border deals, regulatory actions, or macro shocks beyond a generic CPI headline in the scraped text.

Counterpoint

Insider sales are often scheduled (10b5-1) or driven by diversification and trust mechanics, so the negative signal may be overstated.

Key entities

  • Energizer Holdings, Inc.

    Reporting owners bought 60,000 shares for about $1.23M at roughly $20.20 to $20.75 on July 9-10.

  • Gloo Holdings, Inc.

    Grace & Mercy Foundation bought 923,076 shares at $3.25 as part of a committed offering purchase.

  • IPERIONX Ltd

    CEO and executive chairman bought shares around A$3.58 on July 10 and July 13 after a sharp recent decline.

  • Caris Life Sciences, Inc.

    Director Jon Halbert (via LAH Investments) bought 68,000 shares at a weighted average $14.56 on May 15.

  • Arista Networks, Inc.

    CEO/Chairperson Ullal sold 242,422 shares for about $45.6M under Rule 10b5-1 plans on July 9.

Related articles

$DELLMedAI 8/10

Dell Failed to Defeat Challenge to $11 Billion Navy Contract

Dell Federal Systems LP lost a legal bid to dismiss a challenge to its $11.4 billion US Navy contract. The US Court of Federal Claims ruled Dell did not prove Minburn Technology Group's claim lacked merit. The contract involves cloud subscriptions and Microsoft products. Judge Loren A. Smith denied Dell's motion to dismiss.

$DELLHigh

Why Is Dell Stock Sliding Ahead of Q2 Earnings? - Dell Technologies (NYSE:DELL)

Dell Technologies (DELL) stock fell 2% due to concerns over potential semiconductor tariffs affecting its hardware products. The company is set to report Q2 earnings on September 1, 2026, with EPS and revenue estimates up year-over-year. Analysts have mixed ratings but generally positive price targets. DELL is a significant holding in several ETFs, which could amplify trading activity.

$DELLMedAI 8/10

DELL's Strong AI Server Backlog Boosts Prospects: What's Ahead?

Dell reported a record $51.3B AI backlog and $16.1B in AI server revenues for fiscal Q1 2027, up 757% YoY. The company raised its fiscal 2027 AI server revenue guidance to $60B, citing strong demand from enterprises and neocloud providers. Dell's ISG revenues grew 181% YoY to $29B, with operating income up 206% to $3.1B. The company faces competition from NVIDIA and Cisco in the AI infrastructure market.

$CAIMedAI 8/10

Caris Life Sciences study finds AI tool could guide pancreatic cancer treatment choice

Caris Life Sciences (NASDAQ: CAI) published a study in npj Precision Oncology on an AI tool for pancreatic cancer treatment. The tool, part of the Caris Molecular Tumor Board Report, predicts patient outcomes for two treatments, with median survival of 16 months for FOLFIRINOX vs. 9.9 months for gemcitabine plus nab-paclitaxel. The company's MI Cancer Seek test, FDA-approved in November 2024, includes this tool.

$CENTLow

Unpacking Q2 Earnings: Central Garden & Pet (NASDAQ:CENT) In The Context Of Other Household Products Stocks

Central Garden & Pet (CENT) reported Q2 revenue of $882.4M, down 8.2% YoY but beating estimates by 0.6%. Spectrum Brands (SPB) saw revenue growth of 7.7%, exceeding expectations. Energizer (ENR) and Church & Dwight (CHD) also reported earnings, with mixed results. Procter & Gamble (PG) missed revenue estimates. Household products stocks showed stable share prices post-earnings.